An Overview Of Drugs Taken During Pregnancy And Its Outcome

Aim is to create awareness among the women of reproductive age group about the risks associated with consumption of drugs during pregnancy . More than 90% of pregnant women take prescription or non-prescription drugs at some time during pregnancy .In general ,unless absolutely necessary ,drugs should not be used during pregnancy because many of them are harmful to the fetus .Pregnancy introduces unique considerations for drug treatment due to its impact on the pharmacokinetics of medications and the potential harm certain drugs can pose to the fetus. While completely avoiding pharmacological treatment in pregnancy is impractical and risky, as some women have pre-existing medical conditions or develop new ones requiring medication, the challenge lies in balancing effective treatment with fetalsafety. Historical incidents, such as thalidomide in the 1960s, highlighted the risks, but it's crucial to note that congenital abnormalities from teratogenic drugs constitute less than 1% of total cases.To address these concerns, the Food and Drug Administration (FDA) established a system in 1979 for assessing the teratogenic risk of drugs. This classification, ranging from Category A (considered safest) to Category X (absolutely contraindicated in pregnancy), helps guide clinicians in making informed therapeutic decisions. The article delves into various aspects of drug use during pregnancy, emphasizing the importance of weighing risks and benefits to ensure optimal maternal health while safeguarding the developing fetus.

Authors

Institutions

Publication Details

Journal
Indian Journal of Public Health Research & Development
Published
2024-09-20
DOI
https://doi.org/10.37506/t6zw9c70
Citations
1
Primary Topic
Pharmaceutical studies and practices
Type
article
Field-Weighted Citation Impact
1.11
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An Overview Of Drugs Taken During Pregnancy And Its Outcome

Sahid Aziz, Chinmoyee Deori, Swarnamoni Das, Pallavi Bordoloi
1 citations
Indian Journal of Public Health Research & Development
Pharmaceutical studies and practices
1.11
article

An Overview Of Drugs Taken During Pregnancy And Its Outcome

Sahid Aziz, Chinmoyee Deori, Swarnamoni Das, Pallavi Bordoloi
article en
1 citations

Abstract

Aim is to create awareness among the women of reproductive age group about the risks associated with consumption of drugs during pregnancy . More than 90% of pregnant women take prescription or non-prescription drugs at some time during pregnancy .In general ,unless absolutely necessary ,drugs should not be used during pregnancy because many of them are harmful to the fetus .Pregnancy introduces unique considerations for drug treatment due to its impact on the pharmacokinetics of medications and the potential harm certain drugs can pose to the fetus. While completely avoiding pharmacological treatment in pregnancy is impractical and risky, as some women have pre-existing medical conditions or develop new ones requiring medication, the challenge lies in balancing effective treatment with fetalsafety. Historical incidents, such as thalidomide in the 1960s, highlighted the risks, but it's crucial to note that congenital abnormalities from teratogenic drugs constitute less than 1% of total cases.To address these concerns, the Food and Drug Administration (FDA) established a system in 1979 for assessing the teratogenic risk of drugs. This classification, ranging from Category A (considered safest) to Category X (absolutely contraindicated in pregnancy), helps guide clinicians in making informed therapeutic decisions. The article delves into various aspects of drug use during pregnancy, emphasizing the importance of weighing risks and benefits to ensure optimal maternal health while safeguarding the developing fetus.

Indian Journal of Public Health Research & DevelopmentVol. 15(4)
Rain Forest Research Institute (IN), Assam Agricultural University (IN), Assam Medical College (IN)
Openalex Percentile: Top 18%
Pharmaceutical studies and practices
1.11
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.